Francesca Cavazza insider trades: Fennec Pharmaceuticals (FENC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Francesca reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 30, 2020 | FENC | ↑ Buy | 768,000 | $6.25 | $4.8M | Direct | May 4, 2020 (4d) |
| Mar 13, 2018 | RGRX | ↑ Buy | 17,933,673 | $0.23 | $4.1M | Direct | Mar 14, 2018 (1d) |
| Dec 12, 2017 | FENC | ↑ Buy | 294,115 | $8.50 | $2.5M | Direct | Dec 14, 2017 (2d) |
| Nov 29, 2017 | SNGX | ↓ Sell | 293,510 | $2.12 | $622K | Indirect | Dec 1, 2017 (2d) |
| Nov 29, 2017 | SNGX | ↑ Buy | 293,510 | $2.12 | $622K | Direct | Dec 1, 2017 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other FENC insiders
Open-market trades in the last 12 months
About Francesca Cavazza's insider trades
Francesca Cavazza is a 10% owner of Fennec Pharmaceuticals (FENC). Since Nov 29, 2017, Francesca has reported 4 open-market purchases worth $12.0M and 1 sale worth $622K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (5 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FENC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.